TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX)

102 filings reported holding TCRX - TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share as of Q4 2024.
TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX) has 87 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 41.5M shares of 52.4M outstanding shares and own 79.25% of the company stock.
Largest 10 shareholders include Lynx1 Capital Management LP (5.36M shares), EcoR1 Capital, LLC (5M shares), BlackRock, Inc. (4.96M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (3.5M shares), BVF INC/IL (2.99M shares), BAKER BROS. ADVISORS LP (2.78M shares), VANGUARD GROUP INC (2.38M shares), Propel Bio Management, LLC (2.09M shares), Checkpoint Capital L.P. (1.76M shares), and Deer Management Co. LLC (1.25M shares).
This table shows the top 87 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.